← FDA Drug Approvals (Drugs@FDA)

MAVYRET

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2021-06-10

Drug application

FDA Application #

NDA215110

Application type

New Drug Application

Brand name

MAVYRET

Generic name

GLECAPREVIR AND PIBRENTASVIR

Active ingredients

GLECAPREVIR; PIBRENTASVIR

Dosage form

PELLETS

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

AbbVie Inc.

First approval

2021-06-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown